# Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.

> **NCT00399659** · PHASE3 · TERMINATED · sponsor: **Novartis** · enrollment: 360 (actual)

## Conditions studied

- Opioid-induced Constipation

## Interventions

- **DRUG:** Tegaserod

## Key facts

- **NCT ID:** NCT00399659
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-11
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 360 (ACTUAL)
- **Why stopped:** This study was terminated early as a result of regulatory action suspending tegaserod use in 2007
- **Last updated:** 2012-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00399659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00399659, "Safety and Efficacy of Tegaserod in Opioid-induced Constipation in Patients With Non-cancer Pain.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00399659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*